Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis.

Cancers (Basel) · 2024 · PMC11048847 · PMID 38672674

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

showed a trendp = 0.059so close (0.05 < p ≤ 0.1)

Patients with involvement of fewer organs showed a trend towards better OS in patients with ≤2 vs. >2 organ involvement: median OS was 36 vs. 6 months (log-rank HR: 2.05; 95% CI: 0.75–5.56; p = 0.059), respectively.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.